NEW YORK (
CHANGE IN RATINGS
(BRKR) downgraded at BofA/Merrill from Buy to Underperform, Bank of America/Merrill Lynch said. Margin expansion could take longer than expected. $13.50 price target.
(CHK - Get Report) downgraded at Brean from Buy to Hold, Brean Murray said. Company is leveraged to lower natural gas prices.
(CREE - Get Report) downgraded at Ticonderoga from Buy to Neutral, Ticonderoga said. Company is seeing lower margins and lacks sales visibility.
Cree upgraded at ThinkEquity from Hold to Buy, ThinkEquity said. $30 price target. Valuation call, based on a $30 price target.
downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $50 price target. Company is facing higher credit costs and narrower margins.
downgraded at UBS to Neutral from Buy, UBS said. $46 price target. Subscriber growth likely to slow.
rated new Buy at ThinkEquity. $100 price target. Sapien catheter should drive near-term growth.
(EXPE - Get Report)
rated new Underweight at JP Morgan. $31 price target. Company is facing increased competition.
(GES - Get Report)
downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $29 price target. Company faces currency headwinds.
downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Company faces several potential growth headwinds.
Hudson City Bancorp
downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Stock appears fully valued at current levels.
downgraded at BMO from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $25 price target.
downgraded at Keybanc from Buy to Hold, Keybanc said. Mild weather is hurting HVAC demand.
upgraded at Credit Suisse from Underperform to Neutral, Credit Suisse said. $13 price target. Strip activity is showing steady gains.
downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call, based on a $63 price target.
downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Company faces earnings headwinds in the new year.
rated new Neutral at Credit Suisse. $72 price target. Company remains highly leveraged to declining department store traffic.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts